SSZ
SSZ is a multi-target inhibitor, which targets multiple pathological mechanisms of Alzheimer's disease (AD) . SSZ targets acetylcholinesterase, butyrylcholinesterase, β-site amyloid precursor protein cleavage enzyme 1 (BACE1), and γ-secretase. SSZ ameliorates Alzheimer’s diseases and exhibits neuroprotective effect in mice[1].
Product Specifications
CAS Number
[1262287-23-9]
UNSPSC
12352005
Target
Beta-secretase; Cholinesterase (ChE) ; γ-secretase
Type
Reference compound
Related Pathways
Neuronal Signaling; Stem Cell/Wnt
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/ssz.html
Smiles
ClC1=CC(C2=CNC3=C2C=CC=N3)=CC(NC4CCCCC4)=N1
Molecular Formula
C18H19ClN4
Molecular Weight
326.82
References & Citations
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-163885/SSZ-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-163885/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items